East China Pharmaceutical Group

Huadong Medicine is a leading Chinese pharmaceutical company headquartered in Hangzhou, specializing in the R&D, manufacturing, and sales of pharmaceutical products and medical aesthetics. The company has a diversified portfolio covering oncology, immunology, nephrology, and diabetes, with a significant focus on GLP-1 agonists and antibody-drug conjugates. Beyond traditional therapeutics, Huadong is a major player in the global medical aesthetics market through its subsidiary Sinclair. It operates an integrated business model that includes pharmaceutical commerce and retail, alongside its innovative drug development efforts. The company is listed on the Shenzhen Stock Exchange and is a key member of the China Grand Enterprises group.